Found: 184
Select item for more details and to access through your institution.
Metabolic enzyme expression in dopaminergic neurons in Parkinson's disease: an in situ hybridization study.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Biochemical abnormalities and excitotoxicity in Huntington's disease brain.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Mitochondria in the etiology and pathogenesis of Parkinson's disease.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Anaesthetics increase light emission from aequorin at constant ionised calcium.
- Published in:
- Nature, 1980, v. 284, n. 5752, p. 168, doi. 10.1038/284168a0
- By:
- Publication type:
- Article
Novel pharmacological targets for the treatment of Parkinson's disease.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 10, p. 845, doi. 10.1038/nrd2087
- By:
- Publication type:
- Article
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 4, p. 1489, doi. 10.1007/s10072-023-07173-1
- By:
- Publication type:
- Article
Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37454-4
- By:
- Publication type:
- Article
Measuring the Effects of Therapy in Parkinson Disease—Reply.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Neuroprotection in Parkinson Disease: Mysteries, Myths, and Misconceptions.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 3, p. 358, doi. 10.1001/jama.291.3.358
- By:
- Publication type:
- Article
Advances in neurological research and practice.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Sirkka-Liisa Leinonen.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Neurology in evolution 2014-2015.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Practical recommendations for the process of proposing, planning and writing a neurological management guideline by EAN task forces.
- Published in:
- European Journal of Neurology, 2015, v. 22, n. 12, p. 1505, doi. 10.1111/ene.12818
- By:
- Publication type:
- Article
The timing of deep brain stimulation for Parkinson disease in the UK from 1997 to 2012.
- Published in:
- European Journal of Neurology, 2015, v. 22, n. 10, p. 1415, doi. 10.1111/ene.12795
- By:
- Publication type:
- Article
The measurement and importance of non-motor symptoms in Parkinson disease.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Recent advances in neurology 2013-2014.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease.
- Published in:
- European Journal of Neurology, 2014, v. 21, n. 5, p. 736, doi. 10.1111/ene.12375
- By:
- Publication type:
- Article
Progress in European neurology 2012-2013.
- Published in:
- European Journal of Neurology, 2013, v. 20, n. 12, p. 1499, doi. 10.1111/ene.12303
- By:
- Publication type:
- Article
Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease.
- Published in:
- European Journal of Neurology, 2013, v. 20, n. 2, p. 271, doi. 10.1111/j.1468-1331.2012.03840.x
- By:
- Publication type:
- Article
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease.
- Published in:
- European Journal of Neurology, 2013, v. 20, n. 1, p. 180, doi. 10.1111/j.1468-1331.2012.03822.x
- By:
- Publication type:
- Article
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease.
- Published in:
- European Journal of Neurology, 2013, v. 20, n. 1, p. 50, doi. 10.1111/j.1468-1331.2012.03712.x
- By:
- Publication type:
- Article
Optimizing treatment for Parkinson's disease.
- Published in:
- European Journal of Neurology, 2012, v. 19, n. 12, p. 1483, doi. 10.1111/ene.12025
- By:
- Publication type:
- Article
Advances in neurology 2011-12.
- Published in:
- European Journal of Neurology, 2012, v. 19, n. 10, p. 1267, doi. 10.1111/j.1468-1331.2012.03870.x
- By:
- Publication type:
- Article
Publishing changes and information delivery in the clinical neurosciences.
- Published in:
- European Journal of Neurology, 2011, v. 18, n. 12, p. 1365, doi. 10.1111/j.1468-1331.2011.03594.x
- By:
- Publication type:
- Article
Comment from the EFNS Scientific Committee on the letter from Gunther Haag concerning Bendsten L et al. EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. Eur J Neurol 2010; 17: 1318-1325.
- Published in:
- European Journal of Neurology, 2011, v. 18, n. 7, p. e83, doi. 10.1111/j.1468-1331.2011.03382.x
- By:
- Publication type:
- Article
The management of Parkinson's disease - what is new?
- Published in:
- 2011
- By:
- Publication type:
- Editorial
LRRK2 as a therapeutic target in Parkinson's disease.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Challenges to the development of disease-modifying therapies in Parkinson's disease.
- Published in:
- European Journal of Neurology, 2011, v. 18, p. 16, doi. 10.1111/j.1468-1331.2010.03324.x
- By:
- Publication type:
- Article
New LRRK2 variants identified in Parkinson's disease.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Summary of GIGYF2 studies in Parkinson’s disease: the burden of proof.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Early versus delayed initiation of entacapone in levodopa-treated patients with Parkinson’s disease: a long-term, retrospective analysis.
- Published in:
- European Journal of Neurology, 2009, v. 16, n. 12, p. 1305, doi. 10.1111/j.1468-1331.2009.02726.x
- By:
- Publication type:
- Article
Perspectives on recent advances in the understanding and treatment of Parkinson’s disease.
- Published in:
- European Journal of Neurology, 2009, v. 16, n. 10, p. 1090, doi. 10.1111/j.1468-1331.2009.02793.x
- By:
- Publication type:
- Article
Levodopa in the treatment of Parkinson’s disease.
- Published in:
- European Journal of Neurology, 2009, v. 16, n. 9, p. 982, doi. 10.1111/j.1468-1331.2009.02697.x
- By:
- Publication type:
- Article
Coenzyme Q<sub>10</sub> and vitamin E deficiency in Friedreich’s ataxia: predictor of efficacy of vitamin E and coenzyme Q<sub>10</sub> therapy.
- Published in:
- European Journal of Neurology, 2008, v. 15, n. 12, p. 1371, doi. 10.1111/j.1468-1331.2008.02318.x
- By:
- Publication type:
- Article
Hunting for genes in essential tremor.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Transient Horner’s syndrome during lumbar epidural anaesthesia.
- Published in:
- European Journal of Neurology, 2008, v. 15, n. 5, p. 530, doi. 10.1111/j.1468-1331.2008.02120.x
- By:
- Publication type:
- Article
Bimodal administration of entacapone in Parkinson’s disease patients improves motor control.
- Published in:
- European Journal of Neurology, 2008, v. 15, n. 3, p. 268, doi. 10.1111/j.1468-1331.2007.02043.x
- By:
- Publication type:
- Article
Uniting Chinese across Asia: the LRRK2 Gly2385Arg risk variant.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
The scientific and clinical basis for future therapies in Parkinson’s disease.
- Published in:
- European Journal of Neurology, 2008, v. 15, p. v, doi. 10.1111/j.1468-1331.2008.02054.x
- By:
- Publication type:
- Article
Progress in neuroprotection in Parkinson’s disease.
- Published in:
- European Journal of Neurology, 2008, v. 15, p. 5, doi. 10.1111/j.1468-1331.2008.02055.x
- By:
- Publication type:
- Article
Progress in Parkinson’s disease.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
PREFACE.
- Published in:
- 2006
- By:
- Publication type:
- Other
RLS patients: who are they?
- Published in:
- European Journal of Neurology, 2006, v. 13, p. 2, doi. 10.1111/j.1468-1331.2006.01587.x-i1
- By:
- Publication type:
- Article
Dopamine agonists and neuroprotection in Parkinson's disease.
- Published in:
- European Journal of Neurology, 2002, v. 9, p. 7, doi. 10.1046/j.1468-1331.9.s3.9.x
- By:
- Publication type:
- Article
Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice.
- Published in:
- 2017
- By:
- Publication type:
- journal article
DNA Methylation of α-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson's Individuals with GBA1 Mutations.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2687, doi. 10.3390/ijms24032687
- By:
- Publication type:
- Article
Oxidative Stress and Parkinson's Disease.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 786, n. 1, p. 217, doi. 10.1111/j.1749-6632.1996.tb39064.x
- By:
- Publication type:
- Article
Missing pieces in the Parkinson's disease puzzle.
- Published in:
- Nature Medicine, 2010, v. 16, n. 6, p. 653, doi. 10.1038/nm.2165
- By:
- Publication type:
- Article